Morbidity and mortality adjudicated per patient
| PRET-1 | PRET-2 | PRET | ||||
|---|---|---|---|---|---|---|
| Platinum | Hydrogel | Platinum | Hydrogel | Platinum | Hydrogel | |
| Death | ||||||
| Total | 0 | 2 (1.6%) | 0 | 0 | 0 | 2 (0.9%) |
| Treatment-related | 0 | 0 | 0 | 0 | 0 | 0 |
| Morbidity (mRS > 2) | ||||||
| Total | 11 (8.8%) | 5 (4.0%) | 2 (2.1%) | 5 (5.0%) | 13 (5.9%) | 10 (4.4%) |
| Treatment-related | 5 (4.0%) | 2 (1.6%) | 1 (1.0%) | 2 (2.0%) | 6 (2.7%) | 4 (1.8%) |
| Any stroke | 11 (8.8%) | 5 (4.0%) | 8 (8.2%) | 9 (9.0%) | 19 (8.6%) | 14 (6.2%) |
| Any complication | 8 (6.4%) | 4 (3.2%) | 1 (1.0%) | 2 (2.0%) | 9 (4.1%) | 6 (2.7%) |
| No complication | 95 (76.0%) | 107 (85.6%) | 86 (88.7%) | 83 (83.0%) | 181 (81.5%) | 190 (84.4%) |
| Withdrawn | 0 | 2 (1.6%) | 0 | 1 (1.0%) | 0 | 3 (1.3%) |
| Fisher exact test P value | .052 | .612 | .174 | |||